▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁A 3.984375
▁more 5.7109375
▁manage 9.0
able 0.0037384033203125
▁and 2.244140625
▁sa 2.283203125
fer 7.963180541992188e-05
▁alternative 1.666015625
▁might 6.4140625
▁be 0.1898193359375
▁medical 2.681640625
▁mar 0.178466796875
iju 0.0036640167236328125
ana 0.0005488395690917969
. 1.5126953125
▁However 2.90625
, 0.00722503662109375
▁the 1.5947265625
▁legal 4.23828125
▁status 1.1962890625
▁and 2.75390625
▁novel 9.140625
ty 0.6630859375
▁of 0.210205078125
▁this 1.689453125
▁drug 2.091796875
▁do 5.02734375
▁not 0.0703125
▁allow 1.029296875
▁finding 8.7578125
▁a 2.337890625
▁large 4.3828125
▁number 1.4384765625
▁of 0.0037708282470703125
▁studies 1.3291015625
▁on 1.5361328125
▁its 0.98193359375
▁effect 2.060546875
iveness 0.437255859375
. 0.9619140625
▁Specifically 8.1953125
, 0.11529541015625
▁it 2.73046875
▁concerns 4.8359375
▁the 0.64697265625
▁emot 7.37109375
ional 0.01727294921875
▁condition 5.36328125
▁of 0.3837890625
▁patients 0.71875
▁experien 6.29296875
cing 3.445148468017578e-05
▁chron 1.1298828125
ic 0.0023956298828125
▁pain 0.0987548828125
. 0.65380859375
▁This 3.150390625
▁research 2.99609375
▁paper 6.21484375
▁a 2.185546875
ims 0.0004074573516845703
▁to 0.0924072265625
▁analyze 3.06640625
▁levels 9.6640625
▁of 0.0341796875
▁de 0.54736328125
pression 0.03619384765625
▁and 0.26953125
▁anx 0.042236328125
iety 0.0012140274047851562
▁among 0.798828125
▁people 3.26171875
▁receiving 0.94482421875
▁ther 8.0078125
apy 0.33935546875
▁by 5.26171875
▁comparing 7.94921875
▁the 0.9873046875
▁effects 2.169921875
▁of 0.0303192138671875
▁ph 2.455078125
arma 0.039642333984375
ce 0.0011568069458007812
ut 7.176399230957031e-05
ical 0.00390625
▁op 0.305419921875
io 0.162841796875
ids 0.058685302734375
▁and 0.275390625
▁MM 1.2138671875
. 1.0
<0x0A> 1.0068359375
The 1.3349609375
▁study 2.015625
▁was 2.06640625
▁conducted 0.7421875
▁in 1.529296875
▁the 1.4443359375
▁form 2.197265625
▁of 0.006374359130859375
▁collection 10.03125
▁and 1.6943359375
▁analysis 0.6806640625
▁of 0.04559326171875
▁statistical 4.203125
▁data 0.120361328125
. 0.89599609375
▁Part 4.94921875
icip 0.06683349609375
ants 0.04595947265625
▁were 0.70361328125
▁rec 3.2578125
ru 0.0010690689086914062
ited 4.839897155761719e-05
▁for 4.05078125
▁six 7.5546875
▁months 0.52197265625
▁at 3.771484375
▁two 2.498046875
▁major 5.4453125
▁pain 3.078125
▁relief 5.24609375
▁cent 1.5498046875
ers 0.07904052734375
▁in 0.70947265625
▁Israel 4.3203125
. 0.41552734375
▁The 1.1923828125
▁research 2.166015625
ers 1.505859375
▁used 2.705078125
▁The 8.0625
▁De 4.21484375
pression 0.01334381103515625
▁Module 10.1171875
▁of 0.95947265625
▁the 0.32568359375
▁Pat 2.287109375
ient 0.007503509521484375
▁Health 0.08447265625
▁Question 0.013946533203125
naire 0.0183258056640625
▁and 3.3515625
▁the 0.73095703125
▁General 1.6826171875
ized 0.69140625
▁An 0.016021728515625
x 0.0001443624496459961
iety 0.002651214599609375
▁Dis 0.5146484375
order 0.034881591796875
▁Sc 1.205078125
ale 0.068359375
▁to 1.7373046875
▁interview 7.06640625
▁participants 2.017578125
, 3.697265625
▁evaluate 5.56640625
▁their 0.7431640625
▁answers 6.48828125
, 0.853515625
▁and 0.1422119140625
▁conduct 4.4453125
▁the 2.296875
▁study 2.2421875
. 0.224609375
▁To 5.09375
▁specifically 9.8828125
▁evaluate 2.580078125
▁and 4.35546875
▁compare 0.9423828125
▁the 0.338134765625
▁prob 11.1328125
abilities 0.1806640625
▁of 0.1295166015625
▁de 0.82421875
pression 0.03790283203125
▁or 4.5859375
▁anx 0.03558349609375
iety 0.0002944469451904297
▁among 1.7216796875
▁the 2.263671875
▁diverse 8.8984375
▁groups 1.564453125
, 1.4130859375
▁the 1.0107421875
▁study 2.673828125
▁used 1.623046875
▁multiple 4.734375
▁log 2.884765625
istic 0.03607177734375
▁regression 0.101318359375
▁analysis 0.6630859375
▁and 2.53125
▁chose 8.8984375
▁medical 7.41015625
▁mar 0.322021484375
iju 0.0015125274658203125
ana 0.00019562244415283203
▁as 0.794921875
▁the 1.083984375
▁control 2.7265625
▁group 0.5537109375
. 0.285888671875
<0x0A> 0.7548828125
This 3.498046875
▁type 6.078125
▁of 0.0064544677734375
▁study 1.6416015625
▁is 1.287109375
▁the 3.41796875
▁most 1.875
▁reve 9.1640625
aling 0.0006284713745117188
▁and 1.0576171875
▁inclus 6.453125
ive 0.0024356842041015625
, 2.328125
▁as 1.884765625
▁it 0.35546875
▁contains 4.9375
▁direct 6.359375
▁responses 4.9921875
▁from 0.8212890625
▁a 3.86328125
▁large 0.923828125
▁number 0.439208984375
▁of 0.003082275390625
▁participants 1.412109375
. 0.62939453125
▁All 4.63671875
▁tools 9.1328125
▁in 4.55859375
▁the 0.658203125
▁form 3.521484375
▁of 0.040771484375
▁question 1.7451171875
na 0.035858154296875
ires 9.489059448242188e-05
▁and 2.076171875
▁scales 3.046875
▁have 3.685546875
▁already 4.4765625
▁been 0.1802978515625
▁used 1.9365234375
▁and 2.080078125
▁proved 4.2265625
▁their 1.796875
▁effic 3.923828125
acy 7.462501525878906e-05
▁for 3.654296875
▁collect 4.59765625
ing 0.0174407958984375
▁analyt 8.265625
ical 0.238525390625
▁data 0.27392578125
. 0.417724609375
▁helps 17.921875
▁It 9.1171875
▁to 3.708984375
▁system 7.58984375
at 1.5908203125
ize 0.023040771484375
▁and 1.591796875
▁class 3.7578125
ify 0.00672149658203125
▁distinct 9.4375
▁kinds 6.05859375
▁of 0.03076171875
▁information 3.251953125
▁for 4.11328125
▁subsequent 4.0625
▁un 8.03125
comp 5.52734375
licated 0.05670166015625
▁services 11.6015625
. 0.64013671875
▁Thus 4.734375
, 0.03369140625
▁research 4.578125
ers 0.65673828125
▁can 1.3779296875
▁compare 3.98046875
▁the 0.9990234375
▁effects 3.078125
▁of 0.1107177734375
▁medic 4.5234375
ations 0.85888671875
▁on 1.78125
▁patients 2.130859375
▁of 4.51171875
▁diverse 4.109375
▁age 2.943359375
▁groups 0.6435546875
, 0.8955078125
▁background 4.9921875
s 0.1893310546875
, 0.0755615234375
▁physical 5.37109375
▁conditions 1.3974609375
, 0.09197998046875
▁emot 5.51171875
ional 0.05633544921875
▁states 1.322265625
, 0.11187744140625
▁and 0.443115234375
▁so 3.134765625
▁on 0.279052734375
. 0.110595703125
<0x0A> 0.69287109375
The 1.1181640625
▁analysis 4.55078125
▁of 0.5771484375
▁any 8.8671875
▁human 6.09765625
▁reaction 4.86328125
▁has 4.5703125
▁a 1.7646484375
▁high 4.4296875
▁potential 3.513671875
▁of 1.6845703125
▁subject 5.96484375
iveness 3.931640625
▁and 1.3974609375
▁bias 2.2890625
, 1.8056640625
▁especially 2.521484375
▁regarding 4.41015625
▁people 4.5390625
▁in 3.951171875
▁severe 4.2890625
▁pain 0.296630859375
▁and 2.638671875
▁un 5.359375
stable 1.8408203125
▁emot 0.814453125
ional 0.1651611328125
▁condition 2.708984375
. 0.08062744140625
▁Perhaps 8.8359375
▁some 4.90234375
▁patients 2.314453125
▁tend 5.52734375
▁to 0.0205230712890625
▁ex 2.578125
agger 0.0014410018920898438
ate 0.005458831787109375
▁their 0.7421875
▁de 5.12109375
press 1.3662109375
ive 0.253173828125
▁state 3.08984375
▁or 1.916015625
▁vice 7.2734375
▁vers 0.014068603515625
a 5.626678466796875e-05
, 1.01953125
▁de 7.3359375
- 4.96875
emph 0.9482421875
as 0.0054931640625
ize 0.143310546875
▁serious 6.66015625
▁difficulties 5.98828125
. 0.88720703125
▁Because 6.01171875
▁the 2.23046875
▁survey 6.1796875
▁responses 6.66796875
▁were 1.5146484375
▁thoroughly 7.94921875
▁anonymous 5.2109375
, 0.46142578125
▁the 1.4169921875
▁research 1.53515625
ers 0.298828125
▁were 1.337890625
▁unable 2.4609375
▁to 0.003498077392578125
▁carefully 8.8203125
▁analyze 1.6044921875
▁each 3.931640625
▁patient 2.462890625
’ 27.1875
s 0.8486328125
▁reaction 3.625
▁and 2.388671875
▁compare 3.55078125
▁it 0.841796875
▁to 1.25
▁the 0.77099609375
▁actual 5.6328125
▁states 7.34375
▁of 0.63720703125
▁condition 7.421875
. 0.406494140625
▁More 6.9140625
▁accurate 3.802734375
▁answers 4.66015625
▁could 2.525390625
▁be 0.85888671875
▁obtained 0.9384765625
▁by 1.3544921875
▁professional 7.546875
▁psych 2.140625
olog 0.327392578125
ists 0.0011539459228515625
▁via 8.0390625
▁personal 3.982421875
▁communication 4.6640625
▁and 1.87109375
▁behavior 7.12109375
al 0.34912109375
▁analysis 2.251953125
. 0.2418212890625
▁However 2.818359375
, 0.003421783447265625
▁this 1.9208984375
▁method 2.783203125
▁of 2.26171875
▁research 2.09765625
▁is 0.93212890625
▁way 7.94921875
▁more 1.8154296875
▁resource 6.5078125
- 0.420166015625
int 0.51123046875
ensive 0.008697509765625
▁and 0.64404296875
▁energy 8.7109375
- 0.11578369140625
consum 0.31884765625
ing 0.0018053054809570312
. 0.63525390625
<0x0A> 0.64404296875
Part 5.5234375
icip 0.09503173828125
ants 0.11358642578125
▁were 1.0771484375
▁rec 1.55859375
ru 0.0011262893676757812
ited 9.083747863769531e-05
▁for 1.1484375
▁six 1.2001953125
▁months 0.0200042724609375
▁at 0.474365234375
▁two 0.1156005859375
▁major 0.39013671875
▁pain 0.036773681640625
▁relief 0.03021240234375
▁cent 0.033599853515625
ers 0.005252838134765625
▁in 0.0665283203125
▁Israel 0.035247802734375
. 0.153076171875
▁All 3.47265625
▁patients 1.55859375
▁experienced 5.609375
▁chron 1.9462890625
ic 0.0024204254150390625
▁pain 0.09478759765625
▁for 3.484375
▁at 0.7333984375
▁least 0.0009765625
▁ 1.0732421875
3 1.451171875
▁months 0.22509765625
. 1.044921875
▁The 1.4560546875
▁study 1.94921875
▁included 2.177734375
▁ 1.1201171875
8 2.869140625
9 2.759765625
0 3.578125
▁participants 1.5244140625
, 1.2275390625
▁of 1.7158203125
▁which 0.40966796875
▁ 0.1494140625
4 1.6259765625
7 2.466796875
4 2.75
▁( 2.146484375
5 0.0938720703125
9 11.1484375
%) 1.0244140625
▁were 0.478759765625
▁treated 4.6015625
▁sole 6.83203125
ly 0.00010669231414794922
▁with 0.456787109375
▁op 0.8095703125
io 0.392822265625
ids 0.1917724609375
, 1.1552734375
▁ 0.5859375
3 1.068359375
2 2.080078125
9 2.5546875
▁( 0.044342041015625
4 1.201171875
1 1.2470703125
%) 0.13623046875
▁were 1.31640625
▁treated 0.51171875
▁with 0.179443359375
▁MM 0.78369140625
, 0.262939453125
▁and 0.162109375
▁ 0.1376953125
7 3.2265625
7 2.41015625
▁( 0.176025390625
8 3.818359375
. 1.140625
6 2.98046875
%) 0.054656982421875
▁acquired 9.6953125
▁both 1.1826171875
▁( 6.96875
Fe 10.1875
ing 2.888671875
old 0.0202178955078125
▁et 1.4306640625
▁al 0.0174560546875
., 0.311767578125
▁ 0.0106201171875
2 0.1610107421875
0 0.00045180320739746094
1 0.399169921875
7 2.046875
). 0.13330078125
▁The 1.3447265625
▁remaining 6.89453125
▁ten 8.1171875
▁participants 1.369140625
▁who 5.51953125
▁did 1.470703125
▁not 0.006511688232421875
▁receive 1.82421875
▁ph 3.080078125
arma 0.0638427734375
ce 0.0014638900756835938
ut 1.895427703857422e-05
ical 0.0033473968505859375
▁op 0.98974609375
io 0.07769775390625
ids 0.0228271484375
▁and 1.6591796875
▁medical 2.310546875
▁mar 0.045013427734375
iju 0.00463104248046875
ana 9.393692016601562e-05
▁were 1.283203125
▁with 6.015625
dra 0.1356201171875
wn 0.0001112222671508789
▁from 0.25927734375
▁the 0.1070556640625
▁analysis 4.6015625
▁in 4.7734375
▁the 1.1591796875
▁research 4.3203125
. 0.7392578125
▁Therefore 4.96875
, 0.00855255126953125
▁it 3.92578125
▁is 0.87548828125
▁not 2.677734375
▁possible 0.6240234375
▁to 0.020111083984375
▁compreh 6.53515625
ens 0.0489501953125
ively 0.010162353515625
▁compare 1.904296875
▁patients 4.79296875
▁taking 4.3203125
▁medic 3.865234375
ations 0.499755859375
▁with 0.98583984375
▁those 1.1796875
▁who 1.1162109375
▁do 1.6708984375
▁not 0.00818634033203125
. 0.8017578125
<0x0A> 0.63525390625
The 1.12890625
▁study 1.693359375
▁conducted 4.75
▁a 2.09765625
▁correlation 5.98046875
▁type 7.44140625
▁of 0.44970703125
▁research 1.92578125
▁with 2.890625
▁variable 7.984375
▁measures 4.57421875
. 1.2587890625
▁It 2.34765625
▁evaluated 4.43359375
▁the 0.55322265625
▁inter 6.40625
dep 3.630859375
end 0.0005125999450683594
ence 0.0099029541015625
▁of 0.57568359375
▁various 3.947265625
▁factors 1.6455078125
▁that 2.7734375
▁affected 4.13671875
▁the 0.55712890625
▁physical 6.921875
▁and 0.951171875
▁emot 0.473388671875
ional 0.0003457069396972656
▁condition 1.0009765625
▁of 0.10467529296875
▁patients 0.59765625
▁experien 4.203125
cing 2.6106834411621094e-05
▁chron 0.5966796875
ic 0.0004634857177734375
▁pain 0.026275634765625
. 0.2293701171875
▁For 3.765625
▁example 0.99658203125
, 0.0182342529296875
▁the 1.2001953125
▁survey 5.16796875
▁showed 3.41796875
▁that 0.400390625
▁the 1.708984375
▁ratio 7.04296875
▁of 0.12152099609375
▁female 4.48828125
▁patients 0.78076171875
▁was 1.87109375
▁remark 9.6015625
ably 0.0005292892456054688
▁higher 0.53466796875
▁in 2.703125
▁the 0.916015625
▁op 4.57421875
i 4.109375
ates 0.08929443359375
▁group 0.266845703125
▁compared 2.73828125
▁to 0.126708984375
▁the 0.499755859375
▁MM 0.471923828125
▁group 0.267578125
. 0.47998046875
▁In 2.90234375
▁turn 4.03125
, 0.0035495758056640625
▁people 6.0859375
▁on 5.5546875
▁op 1.35546875
i 0.4375
ates 0.003330230712890625
▁were 1.056640625
▁more 0.9873046875
▁likely 0.367431640625
▁to 0.05816650390625
▁report 3.103515625
▁major 5.9921875
▁de 0.3935546875
press 1.228515625
ive 0.003681182861328125
▁dis 0.5224609375
orders 1.314453125
. 1.7822265625
<0x0A> 2.462890625
The 1.1201171875
▁question 5.74609375
na 1.3623046875
ires 8.738040924072266e-05
▁used 1.927734375
▁different 8.2265625
▁variable 8.71875
▁measures 0.81982421875
▁to 1.357421875
▁collect 2.419921875
▁information 1.91796875
. 1.638671875
▁For 1.9609375
▁example 0.1802978515625
, 0.00897216796875
▁it 4.1015625
▁included 2.654296875
▁compreh 8.640625
ensive 0.0267486572265625
▁so 6.9140625
cio 0.0252685546875
- 0.4111328125
dem 0.0836181640625
ographic 0.03570556640625
▁data 1.01171875
: 4.87890625
▁gender 1.615234375
, 0.09014892578125
▁age 0.2032470703125
, 0.09075927734375
▁country 4.41015625
, 1.5078125
▁type 4.36328125
▁of 0.059173583984375
▁residence 3.830078125
▁( 3.4296875
urban 2.056640625
/ 2.947265625
r 0.06585693359375
ural 0.0005002021789550781
), 0.237060546875
▁years 5.94140625
▁of 0.169189453125
▁education 0.69677734375
, 0.14990234375
▁and 1.8359375
▁employ 3.654296875
ment 0.0041656494140625
▁status 0.4462890625
. 0.1815185546875
▁Pat 4.15234375
ients 0.0997314453125
▁were 1.150390625
▁also 0.86279296875
▁asked 0.62548828125
▁about 1.12890625
▁their 0.6005859375
▁medical 2.755859375
▁history 0.404296875
▁over 8.7421875
▁the 0.1549072265625
▁years 3.974609375
▁and 1.7958984375
▁the 1.8212890625
▁current 3.40234375
▁presence 5.734375
▁of 0.05584716796875
▁any 2.66796875
▁severe 4.55078125
▁dise 1.4755859375
ases 7.903575897216797e-05
▁such 4.16015625
▁as 0.0039005279541015625
▁heart 2.400390625
▁failure 2.03125
, 0.1907958984375
▁di 1.849609375
ab 0.0018415451049804688
etes 0.004306793212890625
, 0.1241455078125
▁ar 3.8125
th 0.1314697265625
rit 0.0323486328125
is 0.012115478515625
, 0.0439453125
▁and 1.552734375
▁so 0.74609375
▁on 0.0288238525390625
. 0.049896240234375
▁The 1.8564453125
▁third 7.23828125
▁measure 3.927734375
▁of 2.072265625
▁the 0.9794921875
▁question 2.82421875
naire 0.14794921875
▁was 0.99462890625
▁indicated 9.859375
▁by 0.60791015625
▁information 6.515625
▁on 1.576171875
▁any 5.3515625
▁twelve 13.6875
- 1.15234375
month 0.36669921875
▁and 5.78515625
▁lifetime 3.2109375
▁drug 4.65625
▁and 3.4765625
▁alco 0.07745361328125
hol 8.368492126464844e-05
▁consumption 2.595703125
. 0.4697265625
▁In 3.43359375
▁addition 0.76904296875
, 0.130859375
▁the 1.1201171875
▁record 7.8828125
▁included 1.73046875
▁a 2.453125
▁pain 6.4453125
▁measurement 4.3046875
▁scale 1.0068359375
▁from 3.66796875
▁ 0.451171875
0 0.43603515625
▁to 0.408935546875
▁ 0.006855010986328125
1 0.08837890625
0 0.07489013671875
▁to 4.578125
▁evaluate 1.5625
▁dis 5.99609375
com 0.208984375
fort 0.0011768341064453125
▁feelings 7.37890625
▁during 3.291015625
▁the 0.90087890625
▁last 1.443359375
▁month 1.6025390625
. 0.279296875
<0x0A> 1.09765625
Am 6.8828125
ong 0.01238250732421875
▁all 2.408203125
▁participants 1.9853515625
▁in 3.49609375
▁the 0.1727294921875
▁study 0.371337890625
, 0.05804443359375
▁ 0.6591796875
4 1.771484375
2 2.720703125
. 1.765625
2 2.298828125
% 0.1376953125
▁suffered 4.82421875
▁from 0.1375732421875
▁de 1.7421875
pression 0.1533203125
, 1.052734375
▁and 1.7490234375
▁ 0.1524658203125
3 1.71484375
7 2.232421875
% 2.736328125
▁experienced 2.34765625
▁excess 7.828125
ive 0.09332275390625
▁anx 0.25732421875
iety 0.0014333724975585938
. 0.344970703125
▁The 1.423828125
▁pl 11.1875
ur 1.072265625
ality 0.00022304058074951172
▁of 0.19482421875
▁de 3.494140625
press 1.2705078125
ive 0.0231781005859375
▁dis 1.7998046875
orders 0.0584716796875
▁among 3.72265625
▁patients 1.1923828125
▁in 3.576171875
▁the 0.359619140625
▁op 1.4375
i 0.97705078125
ates 0.004573822021484375
, 7.1328125
▁medical 2.908203125
▁mar 0.021697998046875
iju 0.005710601806640625
ana 3.2901763916015625e-05
, 0.11553955078125
▁and 0.06256103515625
▁mixed 6.109375
▁OP 8.7734375
MM 5.72265625
▁groups 0.439208984375
▁number 8.078125
ed 0.01126861572265625
▁ 0.118896484375
5 2.19140625
7 2.478515625
. 0.215087890625
1 2.373046875
%, 0.2462158203125
▁ 0.00457000732421875
2 2.99609375
2 2.431640625
. 0.10247802734375
3 2.228515625
%, 0.118408203125
▁and 0.031402587890625
▁ 0.0029277801513671875
5 3.2265625
1 2.56640625
. 0.16650390625
4 2.1484375
%, 0.3837890625
▁respectively 0.009857177734375
. 0.289794921875
▁The 1.4755859375
▁pl 4.5078125
ur 0.022491455078125
ality 3.063678741455078e-05
▁of 0.04010009765625
▁anx 0.89306640625
iety 0.01032257080078125
▁contained 11.1015625
▁ 0.6484375
4 1.57421875
8 2.37890625
. 0.062347412109375
4 2.310546875
% 0.50390625
▁among 1.431640625
▁OP 6.47265625
▁patients 9.0
, 0.271484375
▁ 0.0955810546875
2 1.4912109375
1 2.41796875
. 0.13134765625
5 2.4296875
% 0.01129150390625
▁among 0.426025390625
▁MM 0.35400390625
▁patients 0.2384033203125
, 0.0123138427734375
▁and 0.01302337646484375
▁ 0.03814697265625
3 1.236328125
8 2.64453125
. 0.156005859375
7 2.2890625
% 0.0135498046875
▁among 0.239990234375
▁OP 4.06640625
MM 0.2220458984375
▁participants 3.64453125
. 0.22265625
▁Pat 5.74609375
ients 0.0213775634765625
▁who 2.3359375
▁took 2.966796875
▁strong 8.1640625
▁op 1.26171875
i 1.3955078125
ates 0.0033397674560546875
▁were 1.73828125
▁t 8.984375
ended 1.205078125
▁to 0.01387786865234375
▁place 10.3046875
▁their 3.65234375
▁pain 2.59375
▁on 3.458984375
▁a 0.8564453125
▁scale 2.220703125
▁of 0.626953125
▁ 0.339111328125
9 2.8359375
▁to 1.330078125
▁ 0.014434814453125
1 0.0233154296875
0 0.092529296875
▁( 2.568359375
Fe 1.6533203125
ing 0.00818634033203125
old 0.0004699230194091797
▁et 0.030731201171875
▁al 0.0009055137634277344
., 0.007343292236328125
▁ 0.0017385482788085938
2 0.000598907470703125
0 3.170967102050781e-05
1 0.00205230712890625
7 0.01377105712890625
). 0.05645751953125
▁They 4.74609375
▁were 1.28515625
▁also 1.35546875
▁an 8.8984375
gu 4.53125
ished 0.037567138671875
▁em 8.5078125
otion 0.010650634765625
ally 0.004001617431640625
▁and 1.1318359375
▁react 6.8359375
ed 0.06005859375
▁rad 9.484375
ically 0.0027561187744140625
▁neg 5.31640625
atively 0.0009737014770507812
▁to 0.347412109375
▁almost 5.23828125
▁all 1.18359375
▁survey 8.53125
▁questions 0.6240234375
. 0.29638671875
▁Pat 4.1875
ients 0.007633209228515625
▁who 1.1220703125
▁took 1.486328125
▁only 5.4609375
▁MM 0.908203125
▁or 3.224609375
▁mixed 3.388671875
▁medic 2.62109375
ations 0.343017578125
▁course 12.6484375
▁had 2.52734375
▁a 1.2470703125
▁significantly 2.513671875
▁more 4.12890625
▁stable 3.458984375
▁emot 1.1865234375
ional 0.006134033203125
▁state 0.7939453125
▁and 1.4130859375
▁cop 5.609375
ed 0.81787109375
▁with 0.732421875
▁pain 1.4658203125
▁more 1.6376953125
▁manage 6.99609375
able 2.4375
. 0.5234375
<0x0A> 0.6708984375
One 5.1796875
▁of 0.603515625
▁the 0.015655517578125
▁major 2.53125
▁limitations 2.681640625
▁is 3.908203125
▁the 0.5234375
▁ins 4.78515625
u 0.01800537109375
fficient 0.1217041015625
ly 4.74609375
▁high 2.982421875
▁response 3.013671875
▁rate 0.1175537109375
, 2.564453125
▁ 4.734375
5 1.9306640625
7 2.048828125
% 2.076171875
▁instead 7.34765625
▁of 0.007171630859375
▁ 0.7265625
7 1.513671875
0 1.4814453125
% 1.1298828125
▁( 1.6416015625
Fe 0.2744140625
ing 0.0038738250732421875
old 0.0005207061767578125
▁et 0.006824493408203125
▁al 0.0006232261657714844
., 0.00513458251953125
▁ 0.0013818740844726562
2 0.000457763671875
0 2.3245811462402344e-05
1 0.0009608268737792969
7 0.006755828857421875
). 0.0440673828125
▁It 2.822265625
▁can 3.201171875
▁be 0.381103515625
▁fairly 8.3359375
▁explained 1.62890625
▁by 0.17333984375
▁the 0.305419921875
▁weak 8.28125
▁focus 7.14453125
▁of 0.473388671875
▁respond 6.296875
ents 0.1309814453125
▁who 3.42578125
▁have 4.01953125
▁overcome 7.98828125
▁severe 2.259765625
▁pain 0.474609375
▁sens 8.7421875
ations 1.1669921875
▁and 1.1923828125
▁de 4.18359375
press 1.779296875
ive 0.254150390625
▁episodes 3.888671875
. 0.623046875
▁It 3.375
▁is 0.82958984375
▁not 2.673828125
▁clear 4.03125
▁how 1.6357421875
▁to 3.580078125
▁use 5.3359375
▁these 2.998046875
▁statistics 3.404296875
, 2.48828125
▁as 1.4453125
▁they 1.369140625
▁still 6.16796875
▁may 4.81640625
▁be 1.37890625
▁relevant 5.3046875
▁for 1.4609375
▁the 1.828125
▁overall 4.515625
▁analysis 3.099609375
. 1.1279296875
